TradeFlare's AI research teams analysed ALMR on 3 market nights between April 23, 2026 and September 22, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 22, 2026 | BUY | $35.05 | $41.36 / $29.79 | -1.7% | not yet | The post-earnings drift suggests momentum could persist for a few weeks. |
| April 27, 2026 | BUY | $24.84 | — / — | -11.0% | -28.5% | Continued positive news flow from the company's precision proteomics leadership. |
| April 23, 2026 | BUY | $24.27 | — / — | +3.2% | -9.3% | Continued positive news sentiment from a successful IPO. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.